Novel monoclonal antibodies against the proximal (carboxy-terminal) portions of MUC16.
The CA125 antigen, recognized by the OC125 antibody, is a tissue-specific circulating antigen expressed in ovarian cancer. The CA125 antigen is encoded by the MUC16 gene cloned by Yin and Lloyd. The full-length gene describes a complex tethered mucin protein present primarily in a variety of gynecologic tissues, especially neoplasms. OC125 and other related antibodies react with glycosylation-dependent antigens present exclusively in the cleaved portion of the molecule. These antibodies are not useful as screening tools, nor can they detect the proximal residual MUC16 protein fragment after cleavage. This has limited its diagnostic and therapeutic applications. Using synthetic peptides, we raised novel-specific antibodies to the carboxy-terminal portion of MUC16 retained by the cell proximal to the putative cleavage site. These antibodies were characterized using fluorescence-activated cell-sorting analysis, enzyme-linked immunoassay, Western blot analysis, and immunohistochemistry. Each of the selected monoclonal antibodies was reactive against recombinant GST-ΔMUC16 protein and the MUC16-transfected SKOV3 cell line. Three antibodies, 4H11, 9C9, and 4A5 antibodies showed high affinities by Western blot analysis and saturation-binding studies of transfected-SKOV3 cells and displayed antibody internalization. Immunohistochemical positivity with novel antibody 4H11 was similar to OC125 but with important differences, including diffuse positivity in lobular breast cancer and a small percentage of OC125-negative ovarian carcinomas that showed intense and diffuse 4H11. Development of such antibodies may be useful for the characterization of MUC16 biology and allow for future studies in targeted therapy and diagnostics.
Dharma Rao
Thapi
T
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Park
Kay J
KJ
Smith-Jones
Peter
P
Iasonos
Alexia
A
Linkov
Irina
I
Soslow
Robert A
RA
Spriggs
David R
DR
D000230:Adenocarcinoma / Q000175:diagnosis / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D000911:Antibodies, Monoclonal / Q000302:isolation & purification / Q000378:metabolism*; D001943:Breast Neoplasms / Q000175:diagnosis / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D018394:CA-125 Antigen / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D045744:Cell Line, Tumor; D002469:Cell Separation; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D008168:Lung / Q000378:metabolism / Q000473:pathology; D008297:Male; D008565:Membrane Proteins / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D010053:Ovary / Q000378:metabolism / Q000473:pathology; D010179:Pancreas / Q000378:metabolism / Q000473:pathology; D011467:Prostate / Q000378:metabolism / Q000473:pathology; D019076:Transgenes / Q000235:genetics / Q000276:immunology
D000911:Antibodies, Monoclonal; D018394:CA-125 Antigen; C451759:MUC16 protein, human; D008565:Membrane Proteins
Int J Cancer. 2002 Apr 10;98(5):737-40
11920644
J Clin Invest. 1981 Nov;68(5):1331-7
7028788
Nat Med. 1998 Jul;4(7):844-7
9662379
Cancer Cell. 2004 Feb;5(2):163-75
14998492
Tumour Biol. 1993;14(5):310-8
8235310
Clin Cancer Res. 2004 Jun 1;10(11):3919-26
15173101
Tumour Biol. 2002 Sep-Oct;23(5):303-14
12595747
Cancer Biol Ther. 2003 Nov-Dec;2(6):702-6
14688481
J Biol Chem. 2001 Jul 20;276(29):27371-5
11369781
Br J Cancer. 1984 Jul;50(1):23-30
6331484
Tumour Biol. 1996;17(6):325-31
8938947
Tumour Biol. 1997;18(5):278-89
9276028
Tumour Biol. 2002 May-Jun;23(3):154-69
12218296
Mol Biol Cell. 2006 Jul;17(7):2931-41
16624867
Gynecol Oncol. 2010 Feb;116(2):240-5
19879639
Hum Pathol. 2002 Oct;33(10):968-74
12395368
Biochem Biophys Res Commun. 2004 Mar 5;315(2):471-6
14766232
Oncogene. 2006 Jan 5;25(1):20-31
16158055
J Biol Chem. 2009 Feb 6;284(6):3739-49
19075018
N Engl J Med. 1983 Oct 13;309(15):883-7
6310399
Br J Cancer. 2008 Aug 5;99(3):520-6
18665193
Gynecol Oncol. 2005 Nov;99(2):267-77
16061277
Int J Gynecol Pathol. 2008 Apr;27(2):161-74
18317227
Nat Rev Cancer. 2004 Jan;4(1):45-60
14681689
Int J Gynecol Cancer. 2005 Nov-Dec;15 Suppl 3:274-81
16343244
Tumour Biol. 2001 Nov-Dec;22(6):348-66
11786729
Cancer Res. 2008 Nov 15;68(22):9231-8
19010895
Biochemistry. 1978 Oct 31;17(22):4807-17
215191